Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 0.497
-4.42 %
$ 8.69 M
Market Cap
0.02
P/E
CASH FLOW STATEMENT
-48.1 M
OPERATING CASH FLOW
-192 K
INVESTING CASH FLOW
52.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
T2 Biosystems, Inc.
| Net Income | -50.1 M |
| Depreciation & Amortization | 859 K |
| Capital Expenditures | -192 K |
| Stock-Based Compensation | 4.35 M |
| Change in Working Capital | -4.04 M |
| Others | -3.5 M |
| Free Cash Flow | -48.3 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (50.1) | (62.0) | (49.2) | (46.8) | (59.0) | (51.2) | (62.4) | (54.8) | (45.3) | (31.4) | (20.6) | (14.5) |
| Depreciation & Amortization | 0.9 | 2.3 | 2.5 | 3.2 | 3.6 | 2.4 | 2.9 | 2.3 | 1.5 | 0.7 | 0.6 | 0.6 |
| Deferred Income Tax | 0 | 0 | (1.0) | (0.3) | 0.3 | 0.6 | 4.8 | 0.1 | 0 | 1 K | 0.5 | 51 K |
| Stock Based Compensation | 4.4 | 6.5 | 7.1 | 3.9 | 5.5 | 9.9 | 4.8 | 4.8 | 4.2 | 1.7 | 0.6 | 0.4 |
| Other Operating Activities | 0.8 | 3.1 | 3.9 | 3.3 | 2.4 | 2.0 | 2.6 | 0.3 | 0.2 | 0.1 | 39 K | 61 K |
| Change in Working Capital | (4.0) | (0.5) | (2.2) | (6.5) | 1.9 | (3.9) | (0.4) | 0.8 | 2.0 | 0.7 | 0.8 | 0.2 |
| Cash From Operations | (48.1) | (50.6) | (38.9) | (43.2) | (45.4) | (40.1) | (47.7) | (46.4) | (37.5) | (28.2) | (18.1) | (13.3) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.2) | (0.3) | (0.5) | (0.8) | (0.8) | (0.6) | (2.5) | (5.5) | (8.0) | (2.1) | (0.5) | (0.3) |
| Other Items | 0 | 10.0 | 25.3 | (35.5) | 0 | 0 | 0 | 0 | 80 K | 0 | 80 K | 0 |
| Cash From Investing Activities | (0.2) | 9.7 | 24.8 | (36.3) | (0.8) | (0.6) | (2.5) | (5.5) | (7.9) | (2.1) | (0.4) | (0.3) |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | (0.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | (0.9) | (1.5) | (1.2) | 11.4 | 9.7 | 15.7 | (0.8) | 4.5 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 43 K | (0.1) | 0.6 | 0.3 | 0.6 | 2.0 | 1.1 | 40.4 | 0 | 0 | 79.6 | 0 |
| Cash From Financing Activities | 52.7 | 29.1 | 20.5 | 85.6 | 6.3 | 49.7 | 18.5 | 51.8 | 45.2 | 73.9 | 39.0 | 4.6 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 4.4 | (11.9) | 6.5 | 6.1 | (39.8) | 8.9 | (31.7) | (0.2) | (0.2) | 43.7 | 20.5 | (9.0) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (48.3) | (51.0) | (39.3) | (44.0) | (46.1) | (40.7) | (50.2) | (51.9) | (45.4) | (30.3) | (18.6) | (13.6) |